Recent Trends in Seroprevalence of Celiac Disease at a Tertiary Care Center.
J Pharm Bioallied Sci
; 16(Suppl 3): S2056-S2058, 2024 Jul.
Article
en En
| MEDLINE
| ID: mdl-39346472
ABSTRACT
It is a retrospective study and all samples received in the laboratory from symptomatic patients for estimation of Immunoglobulin A (IgA) antitissue transglutaminase (IgA anti-tTGA) antibodies are included. Seroprevalence of celiac disease was determined using indirect enzyme-linked immunosorbent assay for IgA anti-tTGA. Out of 8787 serum samples received in the laboratory over a period of four years, the seroprevalence of CD was 2.1, 1.62, 0.72, and 3.3%, respectively.
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Idioma:
En
Revista:
J Pharm Bioallied Sci
Año:
2024
Tipo del documento:
Article
País de afiliación:
India
Pais de publicación:
India